Lactoferrin to prevent pneumonia in babies on breathing machines
Part of Infections, Lungs & breathing clinical trials.
This study tests whether giving lactoferrin (a protein found in breast milk and other body fluids) to newborns on a ventilator (breathing machine) can prevent a lung infection called ventilator-associated pneumonia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby is a newborn (neonate) who needs a breathing machine (ventilator).
- The breathing machine is expected to be needed for at least 48 hours.
- Baby does not have a birth defect in the lungs or airways.
- Baby does not have a serious heart defect from birth.
- Baby does not have an infection at the start of the study (early-onset sepsis).
- Baby did not have severe lack of oxygen during birth (severe perinatal asphyxia).
- No known allergy to lactoferrin.
- No severe stomach or bowel problems (like severe NEC).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving probiotics (good bacteria) can help prevent pneumonia in children who are on a breathing machine in the intensive care unit. If your child is on a ventilator, these friendly bacteria might help keep their lungs healthy.
This trial tests whether giving a nebulized (inhaled) antibiotic called colistimethate sodium can prevent ventilator-associated pneumonia (a lung infection) in children who are on a breathing machine. If it works, this could reduce the risk of serious lung infections in hospitalized children.
This study watches patients in the intensive care unit (ICU) who are on a breathing machine (ventilator) to learn more about pneumonia that can happen from the machine. The goal is to understand how to better prevent and treat this infection.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This study is testing a way to reduce the chance of a certain breathing problem (called NAV) in babies who need a breathing machine in the NICU. If your baby has been on the machine for two days or more, they may be able to join.
Hear when a new Ventilator Associated Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.